A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study
Date issued
2011Journal title
EUROPEAN JOURNAL OF CANCER
Type of content
Publicación de congreso